Legend Biotech (LEGN) Equity Ratio (2019 - 2025)
Historic Equity Ratio for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to 0.59.
- Legend Biotech's Equity Ratio fell 818.39% to 0.59 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.59, marking a year-over-year decrease of 818.39%. This contributed to the annual value of 0.62 for FY2024, which is 796.27% down from last year.
- Per Legend Biotech's latest filing, its Equity Ratio stood at 0.59 for Q3 2025, which was down 818.39% from 0.61 recorded in Q2 2025.
- Legend Biotech's Equity Ratio's 5-year high stood at 0.73 during Q2 2023, with a 5-year trough of 0.0 in Q1 2021.
- Moreover, its 5-year median value for Equity Ratio was 0.63 (2025), whereas its average is 0.55.
- In the last 5 years, Legend Biotech's Equity Ratio plummeted by 2513.76% in 2021 and then skyrocketed by 21153178854.81% in 2022.
- Legend Biotech's Equity Ratio (Quarter) stood at 0.68 in 2021, then decreased by 18.27% to 0.56 in 2022, then rose by 21.05% to 0.68 in 2023, then dropped by 7.96% to 0.62 in 2024, then fell by 5.24% to 0.59 in 2025.
- Its last three reported values are 0.59 in Q3 2025, 0.61 for Q2 2025, and 0.63 during Q1 2025.